Table 2.
Parameter estimation status for protein–protein interactions (PPIs) in mTOR signalling pathway, based on clear cell renal cell carcinoma (ccRCC) and lung squamous cell carcinoma (LUSC) datasets
| Parameter estimation status | ccRCC | LUSC |
|---|---|---|
| Signal-transducing | 59 PPIs | 59 PPIs |
| No | 0 (0.0%) | 1 (1.7%) |
| Yes | 59 (100.0%) | 58 (98.3%) |
| Estimable | 59 PPIs | 58 PPIs |
| No | 13 (22.0%) | 16 (27.6%) |
| Yes | 46 (78.0%) | 42 (72.4%) |
| Selected model | 46 PPIs | 42 PPIs |
| Model X1 | 38 (82.6%) | 37 (88.1%) |
| Model X2 | 6 (13.0%) | 5 (11.9%) |
| Model X3 | 2 (4.3%) | 0 (0.0%) |
|
1 (2.2%) | 1 (2.4%) |
Fifty-nine PPIs were classified as either non-signal-transducing or signal-transducing. Non-signal transduction means that
or
for all patients in the case and control was 0, or
and
were 0. Signal-transducing PPIs were further classified as either non-estimable or estimable. Failed estimation means that the SAS NLMIXED procedure in Eqs. (4.1) and (4.2) failed to produce estimates. Estimable PPIs were subsequently categorised as Models X1, X2, and X3
